"It's a paradigm shift." This is how Prof. Ulf Teichgräber, Director of the Institute of Diagnostic and Interventional Radiology at the University Hospital Jena, describes the improvement in communication with sponsors and CROs through the use of mint Lesion™. Together, Ms. Laura Graziani, study coordinator, Ms. Elisabeth Lammers, study assistant/MTRA, and Prof. Teichgräber describe their journey towards a successful clinical trial center that can now manage up to 40 clinical trials simultaneously.
Where results previously had to be painstakingly entered into Excel spreadsheets, mint Lesion™ has taken over the evaluation of all findings since its introduction in 2015, thus increasing the objectivity and validity of the study results.
Workflow optimization, increased efficiency and reduced errors in clinical trials
Related Resources
Related Resources
Unveiling the Predictive Power of Pericardial Effusion in COVID-19 Outcomes
The COVID-19 pandemic wreaked havoc on healthcare systems worldwide, requiring a comprehensive understanding of disease progression for optimal…
Advancing Childhood Cancer Research: The Role of Technology in Brain Tumor Diagnosis and Treatment
Brain cancers account for more than 15% of childhood cancers and are the second most common childhood cancer [1]. Mint Medical is Going Gray in May…
Unlocking the Power of AI: The Vital Role of Structured Reporting
We all know the phrase “a picture is worth a thousand words”; yet, in specific fields, one thousand words are simply too many and can potentially…